血必净注射液治疗脓毒症的疗效分析

目的：评价血必净注射液对脓毒症的治疗效果。方法：将45例脓毒症患者随机分成2组,对照组（n=22）给予常规治疗;治疗组（n=23）在常规治疗基础上联合应用血必净100ml,静脉滴注1次/d,连用1周。治疗前后对患者进行APCACHEⅡ评分,白细胞计数、中性粒细胞比率及C反应蛋白定量,记录28d死亡率。结果：与对照组比较,治疗组的APCACHEⅡ评分,白细胞计数及C反应蛋白水平明显降低,28d死亡率也明显下降（P〈0.01）。结论：血必净注射液可阻断全身炎症反应综合症（SIRS）的病理反应过程,改善脓毒症患者的预后。

Efficacy analysis of Xuebijing injection in the treatment of sepsis

Objective：To evaluate the effect of Xuebijing injection on the treatment of sepsis. Method：45 septic patients were randomly divided into control group （n=22） and treatment group （n=23）. The same as the control group receiving conventional treatment,the Xuebijing injection was used in the treatment group,a 100 ml per day for a week. The APCACHE Ⅱ score, white blood cell count, neutrophil ratio, C-reactive protein levels and 28 day mortality were recorded after treatment. Result：Compared with the control group,the APCACHE Ⅱ score,white blood cell count, C reactive protein levels and mortality at 28 clays were significantly decreased in the treatment group（P〈0.01）. Conclusion： Xuebijing injection can block the pathological reactions of the systemic inflammatory response syndrome, and improve the prognosis of patients with sepsis.